Loxo Oncology Analysts Recommendations and Consensus

LOXO -- USA Stock  

USD 175.75  2.99  1.67%

The current analyst and expert consensus on Loxo Oncology is Strong Buy with 0 strong sell and 4 strong buy opinions. The current projected target price consensus is 50.33 with 3 analysts opinions. The most common way Loxo Oncology analysists use to provide recommendation to public is financial statements analysis. Many experts also interview Loxo Oncology executives and customers to further validate their buy or sell advice. Please note, the number of analysists providing the opinion is not sufficient to provide adequate consensus on Loxo Oncology. We encourage you to use your own analysis of Loxo Oncology to validate this buy or sell advice. Loxo Oncology buy or sell recommendation module provides average expert sentiment on the projected Loxo Oncology target price to derive its highest and lowest estimates based on projected price volatility of 1.527. Please see also Macroaxis Advice on Loxo Oncology to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

Loxo Oncology Target Price Consensus

Number of Opinions4
Lowered Outlook0
Raized Outlook0
Strong Buy
Macroaxis Recommendation   Exposure   Valuation

Loxo Oncology Target Price Projection

Current Price

Loxo Oncology Market Quote
Low Price175.75Odds
High Price179.47Odds

175.75

Target Price

Analyst Consensus On Target Price
Low Estimate49.0Odds
High Estimate52.0Odds
Number of Analysts3
Standard Deviation1.527

50.333

Loxo Oncology Analysit Ratings

Average Consensus

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Current Thematic Trending

Baby Boomer Prospects
Purchased few shares
Traded few hours ago for 79.19
PowerShares QQQ ETF
Purchased few shares
Traded few hours ago for 179.93
Investor Favorites
Purchased few shares
Traded few hours ago for 281.04
Basic Utilities
Sold one share
Traded few hours ago for 42.84
Dividend Beast
Purchased over 90 shares
Traded few hours ago for 45.12
Dividend Beast
Purchased over 90 shares
Traded few hours ago for 61.59
Please see also Macroaxis Advice on Loxo Oncology to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon. Please also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.